Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Örebro
Clinical trial register · Sweden

Clinical Trials in Örebro, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2219 matching records held by the registry are in this view. Synced 12 Oct 2026, 03:19 UTC
2219
Studies in scope
all four open statuses
1247
Recruiting now
open to new participants
367
Lead sponsors
across recruiting studies
Top sites
Stockholm 930 Gothenburg 631 Lund 404 Uppsala 369 Linköping 236
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Region Örebro County31 Örebro University, Sweden13 AstraZeneca9 Karolinska Institutet7 Uppsala University7
Site location
Stockholm930 Gothenburg631 Lund404 Uppsala369 Linköping236
All 146 locations
Target enrolment
to

Trials with a site in Örebro

183 of 2219 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Not yet open
Region Örebro County
Not applicable
25
Örebro
2027-04-01
Not yet open
Karolinska Institutet
Not applicable
978
Gällivare, Karlskoga, Lycksele, Örebro, Östersund, Skellefteå, Södra Sunderbyn, Stockholm
2026-12
Not yet open
REcovery After Cancer Application
NCT07642492Oesophageal Cancer, Gastric Cancer (Diagnosis)
Karolinska Institutet
Not applicable
250
Gothenburg, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2026-09-15
Not yet open
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
70
Örebro
2026-09-15
Recruiting
Takeda
Phase 3
324
Örebro, Stockholm
2026-09-10
Not yet open
Örebro University, Sweden
Not applicable
24
Örebro
2026-09
Recruiting
Örebro University, Sweden
Not applicable
11
Örebro
2026-09
Recruiting
AstraZeneca
Phase 3
500
Linköping, Lund, Mölndal, Örebro, Stockholm
2026-08-24
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Gothenburg, Jönköping, Karlstad, Lund, Mölndal, Örebro, Stockholm, Uppsala
2026-08-24
Recruiting
AstraZeneca
Phase 3
7,000
Falun, Gothenburg, Karlstad, Linköping, Lund, Örebro, Stockholm, Uppsala
2026-08-21
Recruiting
Novo Nordisk A/S
Phase 3
450
Mölndal, Örebro, Stockholm
2026-08-12
Recruiting
Novo Nordisk A/S
Phase 3
285
Lund, Mölndal, Örebro, Rättvik
2026-08-04
Recruiting
Örebro University, Sweden
Not applicable
20
Örebro
2026-05-25
Recruiting
Ipsen
Phase 3
350
Gothenburg, Örebro, Stockholm, Uppsala
2026-05-14
Recruiting
Karolinska Institutet
Not applicable
1,380
Malmö, Örebro
2026-05-13
Recruiting
Region Skane
Not applicable
1,300
Gothenburg, Linköping, Lund, Örebro, Stockholm
2026-05-06
Recruiting
Selenium Intervention Registry Randomized Trial in Heart Failure
NCT07543562Heart Failure, Heart Failure and Reduced Ejection Fraction, Heart Failure and Mildly Reduced Ejection Fraction, Heart Failure and Preserved Ejection Fraction
Skane University Hospital
Phase 3
4,326
Malmö, Gothenburg, Jönköping, Linköping, Lund, Örebro, Stockholm, Umeå
2026-04-01
Recruiting
Aspects of Adjuvant CDK4/6 Inhibitors in Older Breast Cancer Patients - Focusing on Geriatric Screening
NCT07273357Geriatric Assessment, Adjuvant Drug Therapy, Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Region Jönköping County
Observational
200
Gävle, Jönköping, Kalmar, Linköping, Örebro
2026-04-01
Recruiting
GLSMED Learning Health S.A.
Observational
10,000
Örebro
2026-04-01
Recruiting
Region Skane
Not applicable
300
Lund, Örebro
2026-03-02
Not yet open
The Örebro Severe Traumatic Brain Injury Registry
NCT07398274Severe Traumatic Brain Injury, Severe Brain Injury, Ischemic Stroke, Intracerebral Hemorrhage
András Zoltán Buki
Observational
200
Örebro
2026-02-08
Recruiting
Eli Lilly and Company
Phase 3
300
Lund, Örebro, Östersund, Stockholm, Uddevalla
2026-02-05
Recruiting
Robotic-Assisted Pedicle Screw Placement in Spine Surgery
NCT07461636Pedicle Screw Fixation of Spine
Uppsala University
Observational
7,200
Gothenburg, Jönköping, Kalmar, Linköping, Örebro, Stockholm, Umeå, Uppsala
2026-02-02
Not yet open
Örebro University, Sweden
Not applicable
8
Örebro
2026-02
Recruiting
University Hospital, Linkoeping
Not applicable
600
Gävle, Jönköping, Kalmar, Katrineholm, Kungsbacka, Linköping, Örebro
2026-01-27
Recruiting
Örebro University, Sweden
Not applicable
35
Örebro
2026-01-21
Recruiting
Vastra Gotaland Region
Phase 4
230
Gothenburg, Malmö, Örebro, Stockholm
2026-01-16
Active, closed
Evaluation of the School-based SIM Program in Upper Secondary School Students
NCT07111676Solution-focused Capability, Mental Well-being, Mental Problems, Perceived Stress
Region Örebro County
Not applicable
727
Örebro
2026-01-14
Recruiting
Eli Lilly and Company
Phase 3
150
Malmö, Örebro
2026-01-12
Not yet open
Region Örebro County
Not applicable
220
Örebro
2026-01-10
Not yet open
Region Örebro County
Not applicable
16
Örebro
2026-01-01
Recruiting
Sanofi
Phase 2
144
Örebro, Uppsala
2025-12-29
Recruiting
The Effects of a Probiotic Food Supplement in Hyperuricaemia
NCT07141888Hyperuricemia With or Without Gout
Örebro University, Sweden
Not applicable
99
Örebro
2025-12-16
Recruiting
Region Örebro County
Phase 4
350
Örebro, Uppsala
2025-12-15
Recruiting
Febrile Infants Swedish Study
NCT07134751Febrile Illness Acute, Meningitis, Bacterial, Urinary Tract Infection (Diagnosis), Invasive Bacterial Infection
Region Skane
Observational
2,000
Gothenburg, Helsingborg, Jönköping, Kristianstad, Lund, Malmö, Örebro, Stockholm
2025-12-01
Recruiting
Uppsala University
Phase 4
560
Borås, Eskilstuna, Gothenburg, Karlskrona, Lund, Örebro, Stockholm, Sundsvall
2025-12
Recruiting
Magnus Nilsson
Phase 3
262
Gothenburg, Lund, Örebro, Stockholm, Uppsala
2025-11-05
Recruiting
Bristol-Myers Squibb
Observational
223
Lund, Solna, Örebro
2025-10-08
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Allingsas, Gothenburg, Linköping, Örebro, Stockholm, Uppsala
2025-10-03
Recruiting
Janssen Research & Development, LLC
Phase 3
882
Allingsas, Gothenburg, Linköping, Örebro, Stockholm, Uppsala
2025-10-01
Recruiting
Uppsala University
Not applicable
96
Kalmar, Linköping, Malmö, Örebro, Stockholm, Umeå, Uppsala
2025-09-17
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
Malmö, Stockholm, Uppsala, Örebro, Linköping
2025-09-11
Recruiting
Sustained Cord Circulation at Emergency Cesarean Section
NCT06540222Asphyxia Neonatorum, Fetal Hypoxia
Region Skane
Not applicable
2,200
Gothenburg, Halmstad, Linköping, Lund, Malmö, Örebro, Stockholm, Umeå
2025-09-08
Recruiting
NTC srl
Phase 3
412
Örebro
2025-09-02
Recruiting
Amgen
Phase 3
12,800
Falun, Gothenburg, Helsingborg, Linköping, Lund, Örebro, Stockholm
2025-07-25
Active, closed
AbbVie
Phase 3
573
Danderyd, Solna, Alingsås, Örebro, Linköping
2025-06-17
Recruiting
Örebro University, Sweden
Observational
15
Örebro
2025-06-12
Active, closed
Region Örebro County
Not applicable
15
Örebro
2025-06-10
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Örebro, Stockholm, Uppsala
2025-06-09
Recruiting
Region Stockholm
Phase 3
1,600
Linköping, Örebro, Stockholm, Umeå, Uppsala
2025-06-03
Recruiting
Takeda
Phase 3
225
Örebro, Huddinge, Gothenburg, Lund
2025-05-06
Recruiting
Registry-randomized Comparison of Rehabilitation Regimens After Flexor Tendon Injury in the Thumb
NCT06836349Flexor Tendon Injury, Rehabilitation Program, Flexor Tendon Rupture, Thumb Injury
Karolinska Institutet
Not applicable
380
Linköping, Örebro, Stockholm, Umeå, Uppsala
2025-05-01
Recruiting
Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage
NCT04696523Subarachnoid Hemorrhage, Aneurysmal, Cerebral Injury, Cerebral Ischemia, Cerebral Infarction
DrugXenon
Turku University Hospital
Phase 2
160
Örebro
2025-04-22
Recruiting
Karolinska Institutet
Phase 4
212
Falun, Gothenburg, Linköping, Lund, Malmö, Nörrköping, Örebro, Stockholm
2025-04-08
Recruiting
Sahlgrenska University Hospital
Observational
220
Gothenburg, Linköping, Luleå, Lund, Örebro, Stockholm, Uppsala
2025-04-01
Recruiting
AstraZeneca
Phase 3
990
Gothenburg, Karlskrona, Lund, Örebro, Stockholm
2025-03-25
Recruiting
taVNS AB
Not applicable
128
Lund, Malmö, Örebro, Stockholm, Umeå
2025-03-21
Recruiting
Improved Treatment for Patients With Long-term Opioid Therapy for Non-cancer Pain in Primary Care
NCT06856733Chronic Pain, Chronic Pain Management, Primary Care
Uppsala County Council, Sweden
Not applicable
110
Gävle, Strängnäs, Uppsala, Örebro
2025-03-10
Recruiting
Question Prompt List in Breast Cancer Patients Planned for Neoadjuvant Chemotherapy
NCT06777420Breast Cancer Early Stage Breast Cancer (Stage 1-3), Neoadjuvant Therapy, Shared Decision Making
Region Örebro County
Not applicable
218
Uppsala, Västerås, Örebro
2025-03-01
Recruiting
Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
NCT06419946Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma
DrugsLomustine·Temozolomide
Vastra Gotaland Region
Phase 3
200
Gävle, Gothenburg, Jönköping, Kalmar, Lund, Örebro, Stockholm, Sundsvall
2025-02-01
By invitation
Region Örebro County
Observational
120
Örebro
2025-01-13
By invitation
Region Örebro County
Observational
90,000
Örebro
2024-12-01
Recruiting
Umeå University
Not applicable
176
Falun, Östersund, Södra Sunderbyn, Karlstad, Umeå, Sundsvall, Örebro
2024-11-20
Active, closed
Amgen
Phase 2
409
Gothenburg, Lund, Örebro, Stockholm
2024-11-07
Recruiting
Region Örebro County
Observational
300
Örebro
2024-10-27
Recruiting
Region Örebro County
Not applicable
84
Örebro
2024-10-10
Active, closed
Örebro University, Sweden
Not applicable
35
Örebro
2024-09-23
Active, closed
Development of an Online ACT Intervention for Disorders of Gut-Brain Interaction
NCT06309004Anxiety and Depression, Disorders of Gut-brain Interaction
Örebro University, Sweden
Observational
15
Örebro
2024-09-23
Recruiting
Marie Matérne
Not applicable
60
Örebro
2024-09-20
Active, closed
Örebro University, Sweden
Not applicable
114
Örebro
2024-08-26
Active, closed
Uppsala University
Not applicable
110
Örebro, Uppsala, Umeå, Gothenburg
2024-08-12
Recruiting
Treatment of Adolescent Anorexia Nervosa
NCT06711783Eating Disorders
Region Örebro County
Not applicable
60
Örebro
2024-08-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Lund, Huddinge, Uppsala, Gothenburg, Örebro
2024-07-16
Recruiting
Fibrosis Lessens After Metabolic Surgery
NCT06374875Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Liver Fibrosis
The Cleveland Clinic
Phase 4
120
Linköping, Örebro
2024-07-11
Active, closed
AbbVie
Phase 3
1,400
Solna, Örebro
2024-06-27
Recruiting
Effect of HIgh-flow Therapy in Long-term Oxygen Therapy
NCT06247397Chronic Obstructive Pulmonary Disease Severe, Interstitial Lung Disease, Chronic Respiratory Failure With Hypoxia
Skane University Hospital
Not applicable
310
Karlskrona, Örebro
2024-06-10
Recruiting
Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE
NCT06336317Acute Myocardial Infarction, Cardiovascular Diseases, Inflammatory Response
DrugInfluenza vaccine
Region Örebro County
Phase 4
90
Örebro
2024-04-24
Recruiting
Section for Affective Disorders; Northern Stockholm Psychiatry
Phase 2
100
Gothenburg, Stockholm, Uppsala, Örebro
2024-04-19
Recruiting
Region Örebro County
Phase 3
800
Gothenburg, Linköping, Lund, Örebro
2024-04-04
Recruiting
Region Örebro County
Phase 3
495
Örebro, Uppsala
2024-04-01
Recruiting
Lund University Hospital
Phase 3
308
Gävle, Gothenburg, Jönköping, Karlstad, Linköping, Lund, Örebro, Stockholm
2024-03-04
Recruiting
AstraZeneca
Phase 3
5,250
Gothenburg, Höllviken, Kungsbacka, Lund, Örebro, Stockholm, Umeå, Uppsala
2024-02-21
Recruiting
Pfizer
Phase 3
492
Falun, Örebro
2024-02-08
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Huddinge, Örebro
2023-12-31
Not yet open
University of Dublin, Trinity College
Phase 3
952
Linköping, Lund, Örebro, Stockholm, Uppsala
2023-11
Recruiting
Karolinska University Hospital
Phase 2
370
Malmö, Örebro, Stockholm, Umeå, Uppsala
2023-10-26
Active, closed
Hot Water Immersion After Myocardial Infarction
NCT05725655Cardiac Disease, Cardiac Rehabilitation
Region Örebro County
Not applicable
30
Örebro
2023-10-26
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Eskilstuna, Gävle, Jönköping, Örebro, Stockholm, Sundsvall, Umeå, Västerås
2023-10-24
By invitation
Transfusion of Whole Blood in Acute Bleeding
NCT06019364Blood Transfusion, Acute Bleeding
Sofia Ramström
Observational
150
Örebro
2023-09-10
Recruiting
Region Jönköping County
Observational
600
Falun, Eksjö, Jönköping, Kalmar, Uppsala, Örebro, Linköping, Norrköping
2023-09-01
Not yet open
Region Örebro County
Phase 3
220
Gothenburg, Örebro, Uppsala
2023-08-21
Recruiting
University of Aarhus
Not applicable
554
Gothenburg, Linköping, Malmö, Örebro, Stockholm, Uppsala
2023-05-24
By invitation
Early Signs of Parkinsons Disease in IBS
NCT05573542Parkinson Disease, Irritable Bowel Syndrome
Örebro University, Sweden
Observational
120
Örebro
2023-05-01
Recruiting
Sahlgrenska University Hospital
Not applicable
200
Gothenburg, Örebro
2023-04-01
Recruiting
Use of GnRHa During Chemotherapy for Fertility Protection
NCT05328258Breast Cancer Female, Acute Leukemia, Lymphoma, Osteosarcoma
DrugElacestrant
Kenny Rodriguez-Wallberg
Phase 3
500
Gothenburg, Lund, Örebro, Stockholm, Umeå
2023-03-31
Active, closed
A Randomized Controlled Trial With Rituximab for Psychotic Disorder in Adults
NCT05622201Schizophrenia Spectrum and Other Psychotic Disorders
DrugRituximab
Region Örebro County
Phase 2
123
Örebro
2023-03-21
Active, closed
AstraZeneca
Observational
551
Örebro, Stockholm
2023-02-27
Recruiting
Lars Olaf Cardell
Phase 2/3
360
Lund, Örebro, Stockholm
2023-02-01
Recruiting
Anthos Therapeutics, Inc.
Phase 3
2,500
Danderyd, Örebro, Stockholm
2022-12-27
Active, closed
Bristol-Myers Squibb
Phase 2/3
230
Stockholm, Örebro
2022-12-14
Recruiting
Structured Contraceptive Counseling During Pregnancy
NCT05550064Contraception, Intrauterine Device, Contraceptive Implant, Long-acting Reversible Contraception
Dalarna University
Not applicable
160
Falun, Karlstad, Örebro, Uppsala
2022-11-19
Recruiting
Sven Löffeler
Phase 3
980
Falun, Gothenburg, Helsingborg, Örebro, Östersund, Stockholm, Umeå, Uppsala
2022-11-04
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Falun, Lund, Örebro, Stockholm
2022-10-25
Recruiting
Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer
NCT05377047Breast Cancer Stage IV, Oligometastatic Disease
Vastra Gotaland Region
Phase 3
345
Jönköping, Malmö, Stockholm, Umeå, Örebro, Gothenburg
2022-09-19
Recruiting
Uppsala University
Not applicable
154
Falun, Uppsala, Örebro
2022-09-14
Active, closed
GlaxoSmithKline
Phase 3
3,038
Borås, Gothenburg, Karlskrona, Linköping, Malmö, Örebro, Stockholm, Upplands Vasby
2022-08-10
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Örebro, Solna, Stockholm
2022-07-22
Recruiting
Örebro University, Sweden
Not applicable
100
Örebro
2022-06-22
Active, closed
Pfizer
Phase 3
854
Helsingborg, Stockholm, Borås, Falun, Örebro, Linköping
2022-03-25
Active, closed
COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events
NCT05333068Multivessel Coronary Artery Disease, Ischemia, Vulnerable Plaque, Coronary Artery Disease
Diagram B.V.
Not applicable
1,223
Linköping, Lund, Örebro, Stockholm
2022-03-16
Recruiting
Lymphedema After Urologic Surgery
NCT05264337Urinary Bladder Neoplasms, Prostatic Neoplasms, Testicular Neoplasms, Penile Cancer
Vastra Gotaland Region
Observational
400
Gothenburg, Örebro
2022-03-14
Active, closed
Eli Lilly and Company
Phase 3
368
Stockholm, Örebro
2022-03-11
Active, closed
Region Örebro County
Observational
57
Örebro
2022-02-22
Active, closed
Region Örebro County
Not applicable
100
Örebro
2022-01-03
Recruiting
Interceptive Maxillary Expansion to Relief Anterior Crowding in the Mixed Dentition
NCT06187337Crowding of Anterior Maxillary Teeth, Orthodontics, Interceptive, Orthodontics, Corrective, Palatal Expansion Technique
Region Örebro County
Not applicable
60
Jönköping, Örebro
2021-12-20
Recruiting
Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer
NCT04983095Prostate Cancer Metastatic, Radiation Therapy, Positron-Emission Tomography
Karin Soderkvist
Not applicable
118
Lund, Stockholm, Umeå, Jönköping, Örebro
2021-10-27
Recruiting
Pfizer
Phase 3
893
Lund, Borås, Falun, Gothenburg, Luleå, Örebro, Linköping
2021-10-04
Active, closed
Region Örebro County
Not applicable
229
Gävle, Örebro, Västerås
2021-10-01
Active, closed
Ole Frobert, MD, PhD
Not applicable
900
Falun, Gothenburg, Karlstad, Lund, Örebro, Västerås
2021-09-30
Recruiting
Assessment of Anorectal Function in Patients With Inflammatory Bowel Disease
NCT05185609Inflammatory Bowel Diseases, Irritable Bowel Syndrome
Region Örebro County
Observational
70
Örebro
2021-09-01
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
1,314
Gothenburg, Malmö, Örebro, Stockholm, Uppsala
2021-08-25
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Falun, Gothenburg, Jönköping, Linköping, Malmö, Norrköping, Örebro, Uppsala
2021-08-14
By invitation
Philips Clinical & Medical Affairs Global
Not applicable
3,212
Lund, Örebro
2021-06-17
Active, closed
Biogen
Phase 3
548
Örebro, Stockholm, Uppasala
2021-05-25
Active, closed
Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®
NCT04896853COVID-19 Acute Respiratory Distress Syndrome, Influenza A, Metapneumovirus Pneumonia, Respiratory Syncytial Virus (RSV)
NextCell Pharma Ab
Phase 1
9
Örebro
2021-05-18
Recruiting
University Hospital, Linkoeping
Observational
360
Gothenburg, Örebro, Stockholm, Linköping
2021-05-17
Recruiting
Specific Training After Stoma Surgery
NCT04701853Colon Cancer
Göteborg University
Not applicable
240
Gothenburg, Helsingborg, Örebro, Skövde
2021-05-01
Active, closed
AstraZeneca
Phase 3
1,157
Gothenburg, Örebro, Stockholm, Uppsala, Vaxjo
2021-04-26
Active, closed
Region Örebro County
Not applicable
324
Örebro
2021-03-25
Active, closed
German CLL Study Group
Phase 3
897
Borås, Falun, Gothenburg, Halmstad, Linköping, Luleå, Lund, Örebro
2021-03-01
Active, closed
Region Örebro County
Not applicable
75
Örebro
2021-02-15
Active, closed
NORTH-REG Dwell-Time Study
NCT04701151Side Effect of Drug
DrugBacillus Calmette-Guerin
Jørgen Bjerggaard Jensen
Phase 4
314
Gothenburg, Örebro, Stockholm
2021-02-03
Active, closed
Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project
NCT04879563Breast Cancer, Prostate Cancer, Quality of Life, Survivorship
Region Örebro County
Phase 2
500
Örebro, Uppsala
2021-02-01
Recruiting
Pfizer
Phase 3
2,100
Lund, Örebro, Stockholm
2021-01-15
Active, closed
Circulating Biomarkers in Oropharyngeal Cancers
NCT05904327Oropharynx Squamous Cell Carcinoma, Oropharynx Cancer, Tonsillar Cancer, Base of the Tongue Carcinoma
Region Örebro County
Observational
130
Örebro
2020-12-01
Recruiting
Karolinska University Hospital
Phase 3
1,020
Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2020-11-27
Active, closed
AbbVie
Phase 1
21
Uppsala, Örebro
2020-11-11
Active, closed
Annika Bergquist
Phase 3
571
Malmö, Umeå, Gothenburg, Karlstad, Lidköping, Örebro, Stockholm, Uppsala
2020-10-01
Active, closed
Region Örebro County
Not applicable
87
Örebro
2020-10-01
Active, closed
Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)
NCT04562805Coronary Artery Disease, Ischemic Heart Disease
Elixir Medical Corporation
Not applicable
2,400
Eskilstuna, Halmstad, Helsingborg, Karlskrona, Karlstad, Lund, Malmö, Örebro
2020-09-30
Recruiting
Nordic Lymphoma Group
Phase 3
300
Borås, Gothenburg, Halmstad, Kalmar, Linköping, Lund, Örebro, Södra Sunderbyn
2020-08-19
Active, closed
AstraZeneca
Phase 3
866
Gothenburg, Örebro, Stockholm, Uppsala, Vaxjo
2020-07-24
Recruiting
Mats Heyman
Phase 3
6,430
Gothenburg, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2020-07-13
Active, closed
Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents
NCT06453590Pancreatic Cancer Non-resectable, Bile Duct Cancer, Papillary Carcinoma, Duodenal Cancer
Region Stockholm
Not applicable
450
Danderyd, Gothenburg, Karlstad, Lund, Malmö, Örebro, Skövde, Stockholm
2020-02-04
Active, closed
Diagnostic Usefulness of Different Types of Gastrointestinal Endoscopic Investigations.
NCT04585516Colo-rectal Cancer, Gastrointestinal Disease
Region Örebro County
Observational
5,000
Örebro
2020-01-01
Recruiting
Thomas Helleday Foundation
Phase 1
50
Huddinge, Örebro
2019-12-03
Active, closed
RhoVac APS
Phase 2
180
Gothenburg, Malmö, Örebro, Stockholm, Umeå
2019-11-19
Recruiting
Optimal Electrical Stimulus During Electroconvulsive Therapy
NCT04057378Depressive Disorder, Major, Depression, Bipolar
Region Örebro County
Phase 4
800
Örebro
2019-10-30
Active, closed
Bristol-Myers Squibb
Phase 3
790
Örebro, Linköping
2019-10-28
Recruiting
Copenhagen University Hospital, Rigshospitalet
Phase 2/3
212
Örebro, Stockholm
2019-10-11
Recruiting
Uppsala University Hospital
Not applicable
75
Gothenburg, Lund, Örebro, Solna, Umeå, Uppsala
2019-09-01
Active, closed
Genetic Causes of Familial Hypercholesterolemia
NCT04101149Familial Hypercholesterolemia
Region Örebro County
Observational
150
Örebro
2019-09-01
Recruiting
Mats Heyman
Observational
500
Gothenburg, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2019-08-29
Active, closed
Effect of Serotonergic Stimulation on the Gut-brain Axis
NCT03920410Healthy, Irritable Bowel Syndrome
Örebro University, Sweden
Not applicable
58
Örebro
2019-04-24
Active, closed
AbbVie
Phase 3
964
Malmö, Falun, Solna, Uppsala, Västerås, Örebro
2019-03-25
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Falun, Jönköping, Örebro, Solna, Umeå
2019-03-21
Active, closed
Acerta Pharma BV
Phase 3
984
Gothenburg, Örebro, Uppsala
2019-02-25
Recruiting
ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer
NCT03903835Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
DrugsXofigo·Cabazitaxel·Zytiga·Capivasertib
Karolinska Institutet
Phase 3
750
Falun, Borås, Jönköping, Kalmar, Karlstad, Örebro, Stockholm, Sundsvall
2019-02-01
Recruiting
Lund University Hospital
Not applicable
100
Gävle, Gothenburg, Jönköping, Karlstad, Linköping, Lund, Örebro, Stockholm
2019-01-22
By invitation
Function of Platelets Used for Transfusions
NCT05038722Thrombocytopenia, Hematologic Malignancy
Sofia Ramström
Observational
240
Linköping, Örebro
2018-11-22
Recruiting
Stefan Carlsson
Phase 3
450
Gothenburg, Stockholm, Umeå, Örebro
2018-10-30
Active, closed
Norwegian University of Science and Technology
Phase 2
212
Gävle, Gothenburg, Linköping, Lund, Örebro, Stockholm
2018-07-31
Active, closed
Vastra Gotaland Region
Phase 4
2,201
Gothenburg, Karlskrona, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2018-06-29
Active, closed
Raija Silvennoinen
Phase 2
120
Borås, Gothenburg, Halmstad, Linköping, Luleå, Lund, Örebro, Skåne
2018-05-31
Recruiting
Jeanette Lundin
Phase 1/2
50
Falun, Gävle, Lund, Gothenburg, Örebro, Stockholm, Umeå, Uppsala
2018-02-23
Active, closed
BeiGene
Phase 3
590
Borås, Gothenburg, Lund, Örebro, Stockholm, Uppsala
2017-10-31
Recruiting
Prostate Cancer Clinical Trials Consortium
Observational
5,000
Malmö, Umeå, Örebro
2017-07-21
Active, closed
Aarhus University Hospital Skejby
Not applicable
1,201
Huddinge, Gothenburg, Örebro, Stockholm
2017-07-05
Active, closed
Karolinska Institutet
Not applicable
750
Gothenburg, Lund, Örebro, Stockholm, Uppsala
2017-05-03
Active, closed
Uppsala University
Not applicable
2,008
Gothenburg, Linköping, Luleå, Örebro, Sundsvall, Umeå, Uppsala, Vaxjo
2016-10-03
Active, closed
Vastra Gotaland Region
Not applicable
74
Gothenburg, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2016-06
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Gothenburg, Malmö, Örebro, Stockholm, Umeå, Uppsala, Vaxjo
2015-11-27
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Örebro, Stockholm, Umeå
2015-11-19
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
Gävle, Gothenburg, Örebro, Stockholm, Uppsala
2015-08
Recruiting
Proton Radiotherapy for Primary Central Nervous System Tumours in Adults
NCT02797366Central Nervous System Tumour, Arteriovenous Malformation
Uppsala University
Phase 2
500
Gothenburg, Linköping, Örebro, Stockholm, Umeå, Uppsala
2015-08
Active, closed
Acerta Pharma BV
Phase 3
535
Gothenburg, Linköping, Lund, Örebro
2015-06-26
Active, closed
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
DrugsLupron·Eligard·Leuprorelin·Xtandi
Pfizer
Phase 3
1,068
Gothenburg, Malmö, Örebro, Stockholm, Umeå, Uppsala
2014-12-17
Active, closed
Eli Lilly and Company
Phase 3
493
Gävle, Örebro, Västerås
2014-11-06
Active, closed
Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer
NCT02568839Early-Stage Breast Carcinoma, HER-2 Positive Breast Cancer
DrugsTrastuzumab emtansine·Pertuzumab·Trastuzumab·Docetaxel
Thomas Hatschek
Phase 2/3
202
Örebro, Gothenburg, Lund, Stockholm, Sundsvall, Umeå, Uppsala
2014-11
Active, closed
Norwegian University of Science and Technology
Not applicable
177
Gävle, Gothenburg, Lund, Örebro, Stockholm, Umeå
2014-07-08
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Gothenburg, Örebro, Stockholm, Umeå, Uppsala
2013-10-14
Active, closed
AstraZeneca
Phase 3
510
Linköping, Örebro, Uppsala
2013-09-25
Active, closed
Karolinska University Hospital
Phase 3
2,017
Gävle, Gothenburg, Karlstad, Linköping, Lund, Malmö, Örebro, Stockholm
2007-02
Rows per page Showing 1–183 of 183
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-sweden/city/rebro

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,219 studies in total at the last sync on 12 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 183 of those studies with a site in Örebro.

How many clinical trials are recruiting in Örebro?

98 of the 183 studies on this page are recruiting new participants as of the 12 Oct 2026, 03:19 UTC sync. A further 11 have not yet opened recruitment, 67 are active but closed to new participants, and 7 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Örebro), 183 studies
PhaseStudiesRecruitingShare
Phase 3653635.5%
Not applicable582931.7%
Observational281515.3%
Phase 21357.1%
Phase 4974.9%
Phase 2/3643.3%
Phase 1311.6%
Phase 1/2110.5%

Most active sponsors

Lead sponsors with the most studies (Örebro)
Lead sponsorStudiesRecruiting
Region Örebro County3111
Örebro University, Sweden136
AstraZeneca95
Karolinska Institutet74
Uppsala University75
Vastra Gotaland Region64
Pfizer53
AbbVie40
Bristol-Myers Squibb42
Eli Lilly and Company42
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.